Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (105)	2/17/2000 5:28:00 PM
From: scaram(o)uche	Read Replies (1) of 1833

Mike: >> I know everybody else is here for the other angles, but the chip is what intrigued me. << As you know, the market cap at today's close was 38 million. Pick whichever underlying strength tickles you, and odds are that it's sufficient justification for an investment. No? A couple of points.... (1) I'll stick with my estimate of $0 to be derived from SmithKline. Would love to stick any surprises into a valuation model, however; (2) I have been unable to find any guidance regarding the royalty from OSIP (Solvay or OSIP-proprietary). I'll stick with my total guess of 6%. However, given the new business strategy of non-exclusive licensing of the genomics platform, I'll raise projections for milestone, license and royalty revenues. Cheers! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next